Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2bm9 | SAM | Cephalosporin hydroxylase CmcI |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 2bm9 | SAM | Cephalosporin hydroxylase CmcI | / | 1.000 | |
| 1w87 | NAP | Ferredoxin--NADP reductase | 1.18.1.2 | 0.450 | |
| 2br5 | SAH | Cephalosporin hydroxylase CmcI | / | 0.447 | |
| 1e5q | NDP | Saccharopine dehydrogenase [NADP(+), L-glutamate-forming] | 1.5.1.10 | 0.445 | |
| 3k9v | CPS | 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | / | 0.442 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.440 | |
| 4cpd | NAD | Alcohol dehydrogenase | / | 0.440 | |
| 4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.440 |